SOTYKTU

Identification of Sotyktu

No description

Google image searchProduct monograph

Active ingredient

deucravacitinib, 6 MG

DIN: 02533030

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: BRISTOL-MYERS SQUIBB CANADA

Date: 14-FEB-2023

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AF — Janus-associated kinase (JAK) inhibitors (ATC, ATC/DDD)
• L04AF07 — DEUCRAVACITINIB (ATC/DDD)

External Links for Sotyktu

Search on Google

• Sotyktu side effects
• Sotyktu dosage
• deucravacitinib side effects
• deucravacitinib dosage

Bristol-Myers Squibb Canada

Go to Bristol-Myers Squibb website to see drug product details. Sometimes you can find sotyktu photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.